Evidence mapPaperPMID 32526044Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2020

Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.

Juliana Rodriguez, Angélica Fletcher, Fernando Heredia, Robinson Fernandez, Heidy Ramírez Salazar, Daniel Sanabria, Javier Burbano Luna, Eduardo Guerrero, Marc-Edy Pierre, Gabriel J Rendón and 22 more

Open access · greenAbstract read
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. An audit of hysterectomy in a teaching hospital in India: Story of a decade.Journal of the Chinese Medical Association : JCMA · 2023
    Article
  4. Gynecologic radiation therapy in low and middle income countries during the COVID-19 pandemic.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 10 countries.

Juliana RodriguezDepartment of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Angélica FletcherDepartment of Gynecologic Oncology, Centro de Investigaciones Oncológicas Clínica San Diego - CIOSAD, Bogota, Colombia.
Fernando HerediaDepartment of Gynecology and Obstetrics, School of Medicine, Universidad de Concepción, Concepción, Chile.
Robinson FernandezUnit of Gynecologic Oncology, Misión Médica SAS, Barranquilla, Colombia.
Heidy Ramírez SalazarDepartment of Gynecologic Oncology, Fundación Valle del Lili, Cali, Colombia.
Daniel SanabriaSection of Gynecologic Oncology, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Javier Burbano LunaDepartment of Gynecologic Oncology, Fundación Valle del Lili, Cali, Colombia.
Eduardo GuerreroDepartment of Radiotherapy Oncology, Instituto Nacional de Cancerología, Bogota, Colombia.
Marc-Edy PierreDepartment of Oncology, Centro de Investigaciones, Oncológicas Clínica San Diego - CIOSAD, Bogota, Colombia.
Gabriel J RendónDepartment of Gynecologic Oncology, Instituto de Cancerología-Las Américas-Auna, Hospital General, Medellín, Colombia.
Indira RoseroUnit of Cancer, Centro Médico Imbanaco, Clínica Nuestra Señora de los Remedios, Cali, Colombia.
Lina María TrujilloDepartment of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Reitan RibeiroDepartment of Surgical Oncology, Erasto Gaertner Hospital, Curitiba, Brazil.
Glauco BaiocchiDepartment of Gynecologic Oncology, AC Camargo Cancer Center, Sao Paulo, Brazil.
Aldo Lopez BlancoDepartment of Gynecologic surgery, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Magaly MalcaService of Gynecologic Oncology, Hospital Edgardo Rebagliati Martins, Lima, Perú.
Jorge HoeglService of Gynecologic Oncology, Servicio Oncológico Hospitalario, Caracas, Venezuela.
Alfredo Borges GarnicaUnidad de Terapia Antineoplásica (UTAN), Centro Médico Guerra Méndez, Valencia, Venezuela.
Jorge Lasso de la VegaInstituto Oncológico Nacional, Ciudad de Panamá, Panamá.
Santiago ScassoDepartment of Gynecologic Oncology, Hospital Pereira Rossell, Montevideo, Uruguay.
Joel LauferDepartment of Gynecologic Oncology, Hospital Pereira Rossell, Montevideo, Uruguay.
Erick Estuarto EstradaHospital General San Juan de Dios, Ciudad de Guatemala, Guatemala.
Armando Gutierrez CriadoService of Gynecology and Obstetrics, Hospital San Juan de Dios, San José, Costa Rica.
Guillermo Sidney Herbert NuñezInstituto Nacional de Cancerología, Hospital Angeles de Querétaro, Querétaro, México.
David Cantú-de LeonInstituto Nacional de Cancerología, Ciudad de México, México.
Gonzalo MedinaHospital Universitario San Juan de Dios, Tarija, Bolivia.
Luis Pendola GómezService of Mastology, ION Solca, Centro Oncológico Integral (CENONI), Guayaquil, Ecuador.
José SaadiService of Gynecology, Section of Gynecologic Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Florencia NollService of Gynecology, Section of Gynecologic Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Danilo Arévalo SandovalClínica de Gineco-Oncología, San Salvador, El Salvador.
Alexandre Ferreira OliveiraDepartment of Surgery, Juiz de Fora Federal University, Juiz de Fora, Brazil.
Rene ParejaDepartment of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia.
Centro Hospitalario Pereira Rossell · UYFundación Santa Fe de Bogotá · COFundación Valle del Lili · COHospital Italiano de Buenos Aires · ARInstituto Nacional de Cancerología · COAC Camargo Hospital · BRAsociación Colombiana de Gastroenterología · COClínica Santa María · COHospital Clínico Universitario de Caracas · VEHospital Erasto Gaertner · BRHospital General San Juan de Dios · GTHospital San Juan de Dios · CLInstituto de Cancerología Las Américas · COInstituto Nacional de Cancerología · MXInstituto Tecnológico de Querétaro · MXNational Oncologic Institute · PASt Martins Hospital · GBUniversidade Federal de Juiz de Fora · BRUniversidad Pontificia Bolivariana · COUniversity of Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the acceptance rate of treatment alternatives for women with either preinvasive conditions or gynecologic cancers during the COVID-19 pandemic among Latin American gynecological cancer specialists.

methodsTwelve experts in gynecological cancer designed an electronic survey, according to recommendations from international societies, using an online platform. The survey included 22 questions on five topics: consultation care, preinvasive cervical pathology, and cervical, ovarian, and endometrial cancer. The questionnaire was distributed to 1052 specialists in 14 Latin American countries. A descriptive analysis was carried out using statistical software.

resultsA total of 610 responses were received, for an overall response rate of 58.0%. Respondents favored offering teleconsultation as triage for post-cancer treatment follow-up (94.6%), neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer (95.6%), and total hysterectomy with bilateral salpingo-oophorectomy and defining adjuvant treatment with histopathological features in early stage endometrial cancer (85.4%). Other questions showed agreement rates of over 64%, except for review of pathology results in person and use of upfront concurrent chemoradiation for early stage cervical cancer (disagreement 56.4% and 58.9%, respectively).

conclusionLatin American specialists accepted some alternative management strategies for gynecological cancer care during the COVID-19 pandemic, which may reflect the region's particularities. The COVID-19 pandemic led Latin American specialists to accept alternative management strategies for gynecological cancer care, especially regarding surgical decisions.

Indexed as

SARS-CoV-2COVID-19FemaleGenital Neoplasms, FemaleHealth Planning GuidelinesHumansHysterectomyLatin AmericaNeoadjuvant TherapyOvarian NeoplasmsPregnancyPregnancy Complications, NeoplasticSalpingo-oophorectomyUterine Cervical NeoplasmsCancer managementCoronavirusCOVID-19Gynecologic cancerGynecologic neoplasmsLatin AmericaSurvey

Identifiers

PMID32526044
PMCPMC9087623
OpenAlexW3034823399

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.